[2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate

C37H54O11 — CID 163005960

IUPAC[2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate
SMILESCC(=O)OC1C(OC2CC3(C)C4CC=C5C(C=C(O)C(=O)C5(C)C)C4(C)CCC3(C)C2C(C)(O)C(=O)C=CC(C)(C)O)OCC(O)C1O
InChIInChI=1S/C37H54O11/c1-19(38)47-28-27(42)23(40)18-46-31(28)48-24-17-36(8)25-11-10-20-21(16-22(39)30(43)33(20,4)5)34(25,6)14-15-35(36,7)29(24)37(9,45)26(41)12-13-32(2,3)44/h10,12-13,16,21,23-25,27-29,31,39-40,42,44-45H,11,14-15,17-18H2,1-9H3
InChIKeyUMUGPJUWSBVZGS-UHFFFAOYSA-N
MW674.83 g/mol
LogP3.47
Rot. Bonds7

About [2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate

[2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate (PubChem CID 163005960) has the molecular formula C37H54O11 and a molecular weight of 674.83 g/mol. Its IUPAC name is [2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate.

Molecular Properties

Compound Name[2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate
PubChem CID163005960
Molecular FormulaC37H54O11
Molecular Weight674.83 g/mol
Exact Mass674.37
IUPAC Name[2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate
SMILESCC(=O)OC1C(OC2CC3(C)C4CC=C5C(C=C(O)C(=O)C5(C)C)C4(C)CCC3(C)C2C(C)(O)C(=O)C=CC(C)(C)O)OCC(O)C1O
InChIInChI=1S/C37H54O11/c1-19(38)47-28-27(42)23(40)18-46-31(28)48-24-17-36(8)25-11-10-20-21(16-22(39)30(43)33(20,4)5)34(25,6)14-15-35(36,7)29(24)37(9,45)26(41)12-13-32(2,3)44/h10,12-13,16,21,23-25,27-29,31,39-40,42,44-45H,11,14-15,17-18H2,1-9H3
InChIKeyUMUGPJUWSBVZGS-UHFFFAOYSA-N
XLogP3.47
TPSA180.05 Ų
H-Bond Donors5
H-Bond Acceptors11
Rotatable Bonds7
Heavy Atoms48
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500674.83
LogP ≤ 53.47
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze [2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate?
The IUPAC name of [2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate (CID 163005960) is [2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate.
What is the SMILES notation for [2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate?
The canonical SMILES for [2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate is CC(=O)OC1C(OC2CC3(C)C4CC=C5C(C=C(O)C(=O)C5(C)C)C4(C)CCC3(C)C2C(C)(O)C(=O)C=CC(C)(C)O)OCC(O)C1O.
What is the InChIKey of [2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate?
The InChIKey is UMUGPJUWSBVZGS-UHFFFAOYSA-N. The full InChI is InChI=1S/C37H54O11/c1-19(38)47-28-27(42)23(40)18-46-31(28)48-24-17-36(8)25-11-10-20-21(16-22(39)30(43)33(20,4)5)34(25,6)14-15-35(36,7)29(24)37(9,45)26(41)12-13-32(2,3)44/h10,12-13,16,21,23-25,27-29,31,39-40,42,44-45H,11,14-15,17-18H2,1-9H3.
What are the key properties of [2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate?
[2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate has a molecular weight of 674.83 g/mol, XLogP of 3.47, 7 rotatable bonds, 5 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[[17-(2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-4,4,9,13,14-pentamethyl-3-oxo-7,8,10,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-16-yl]oxy]-4,5-dihydroxyoxan-3-yl] acetate is sourced from PubChem (CID 163005960), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).